NCT05746559 ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05713851 Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study Status RECRUITING Phase PHASE2/PHASE3
NCT05645653 Nurse-led Medication Self-management Intervention in the Improvement of Medication Adherence Status UNKNOWN Phase NA
NCT05479331 The Relationship Between Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease and the Risk Involved. Status COMPLETED Phase N/A
NCT05356325 FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease. Status RECRUITING Phase N/A
NCT05243979 The Relation Between Thyroid , Parathyroid Hormones and eGFR in CKD Patients in Assiut Status UNKNOWN Phase N/A
NCT05144971 StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation Status COMPLETED Phase N/A
NCT05125913 Long Term Cardio-Vascular Risk Assessment in CKD and Kidney Transplanted Patients Following SARS-COV-2 Status UNKNOWN Phase N/A
NCT04819217 Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease Status RECRUITING Phase NA
NCT04792320 Oral Absorbent and Probiotics in CKD Patients With PAD on Gut Microbiota, IncRNA, Metabolome, and Vascular Function Status RECRUITING Phase NA
NCT04788914 lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD Status RECRUITING Phase NA
NCT04782297 Long Term Hemodialysis Catheters (LTHD) Post Market Clinical Follow up (PMCF) Status WITHDRAWN Phase N/A
NCT04741074 Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy Status TERMINATED Phase PHASE3
NCT04709120 Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection Status COMPLETED Phase N/A